Status:
COMPLETED
Inflammatory Biomarkers for the Diagnosis of oPRES
Lead Sponsor:
Dunjin Chen
Conditions:
Posterior Reversible Encephalopathy Syndrome
Inflammatory Biomarkers
Eligibility:
FEMALE
16-50 years
Brief Summary
The purpose of this study is to explore the inflammatory biomarkers for the diagnosis of obstetric posterior reversible encephalopathy syndrome.
Detailed Description
The investigators retrospectively collected data (General information, clinical data, biochemical indicators, imaging features, and pregnancy outcome) from pregnant woman diagnosed with PRES to explor...
Eligibility Criteria
Inclusion
- Pregnant women were diagnosed of PE or E.
- All patients were examined the cranial imaging (MRI or CT), and imaging findings meeting the diagnostic criteria of PRES or normal.
- all patients provided written informed consent.
Exclusion
- patients combined with other neurological disorders
- patients combined with mental illness
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2022
Estimated Enrollment :
621 Patients enrolled
Trial Details
Trial ID
NCT05433870
Start Date
July 1 2022
End Date
July 31 2022
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University
Guangzhou, China, 510150